This is a note about the leaked ACTA documents, that have been reported now by several news organizations and bloggers.*
On September 30, 2009, the EU wrote a three page memo on the Internet chapter of ACTA. This is about a week after the USTR held a secret meeting with selected corporate lobbyists and lawyers to debate the ACTA Internet under terms of a tough non-disclosure agreement.
Continue Reading →
While the 6th Round of negotiations of the Anti-Counterfeiting Trade Agreement (ACTA) is taking place in Seoul, Republic of Korea from November 4-6, 2009, the 5th session of the WIPO Advisory Committee on Enforcement (ACE) met from November 2-4, 2009.
Continue Reading →
KEI was asked to look at federal support for research and development on (Enbrel) etanercept.
A November 1, 2009 search of the NIH CRISP database reports 167 federal grants for research on etanercept.
Continue Reading →
The Wellcome Trust convened an “Opinion Formers Conference” on “Counterfeit Medicines: Perspectives and Action” on Monday 26 October 2009. Continue Reading →
On November 4-6, 2009, the next round of negotiations for the Anti-Counterfeiting Trade Negotiations (ACTA) will take place in Seoul, Korea. The following is another strange chapter in the secrecy surrounding this negotiation.
Background
Since ACTA was first announced, KEI has pressed the negotiating governments to provide more transparency, including recently, for example
In discussions about a possible WIPO Treaty for persons who are blind or have other reading disabilities, there have been suggestions by some that voluntary licensing by rights holders presents a sufficient solution to the problem. I studied several publications since 1985 to take a closer look at this viewpoint and find out what were the common perceptions.
Continue Reading →
Korean civil society has asked KEI to disseminate this request for solidarity and action in their efforts to reduce the price of Gleevec, a leukemia treatment pill. The current price is approximately 2,300 USD per month for an adult patient and the Korean government has been sued by Novartis for trying to reduce the price a 14%. Korean civil society is also requesting Novartis to introduce a higher form, 400 mg, in Korea.
REQUEST for Solidarity:
Continue Reading →
This is a work in progress
1824
Louis Braille invented a system of reading and writing by means of raised dots.
1921
Continue Reading →